Mildred Lundgren: These 5 Proposals Are A Clear Road Map for The Future And We Support Them Wholeheartedly
Mildred Lundgren, Chairman of the Board at HHT Sweden, shared on LinkedIn:
”We at HHT Sweden applaud this post and stand behind every single point!
For those of us struggling with a rare diagnosis like HHT (Hereditary Hemorrhagic Telangiectasia), faster diagnosis is not just a matter of better quality of life – it’s crucial for preventing life-threatening complications such as stroke and bleeding.
These five proposals are a clear road map for the future and we support them wholeheartedly.
We look forward to the Government now prioritising these measures and securing the funding required for the strategy to become a reality.”
Quoting Rare Diseases Sweden‘s post:
”Time for a focus on rare health conditions!
In Sweden, 500,000 people live with a rare health condition.
Despite this, they often have to wait years for a diagnosis, face regional differences in care and do not have access to treatments in time.
The government has promised a national strategy – but without money, it risks becoming an empty symbolic act.
We know that long-term investments work – cancer care is the proof.
Now the same effort is required for rare diagnoses.
Here are five suggested measures that would make a big difference for patients with rare health conditions:
- SEK 500 million/year for faster diagnosis and care.
- A national coordinator who drives the strategy forward.
- Better support for patient organisations – so every voice is heard.
- Strengthened role for the Centre for Rare Diseases.
- Faster access to new treatments.
It is time to move from words to action.”
Read the full article here.
Article: Time to focus on rare health conditions

Stay updated with Hemostasis Today.
-
Nov 14, 2025, 11:58Marilena Vrana: Can Public-only Blood Collection Systems Meet the Growing Patient Need for PDMs?
-
Nov 14, 2025, 11:48Cedric Hermans Shares the 1st Illustrated Review Dedicated to Hemophilia B
-
Nov 14, 2025, 10:28Valance Washington: Proud to Share Our Lab’s Latest Publication in Platelets Journal
-
Nov 14, 2025, 10:18Sripal Bangalore and Ajay Kirtane on TUXEDO-2 Comparison Focusing on Diabetic Patients
-
Nov 14, 2025, 10:11Ashley Lawrenson on Her Coagulation Journey Using Automation With the HemoCell and HemoHub
-
Nov 14, 2025, 10:05Kingsley Wheaton: A Year Ago, Omni Was an Idea – Today, It’s a Movement!
-
Nov 14, 2025, 09:58Rucha Patil Takes The National DHR-ICMR Gold Award for Best Technology
-
Nov 14, 2025, 09:48Caitlin Raymond on ”The Plasma Chasers”
-
Nov 14, 2025, 09:42Erin VanDyke on Why They Do In-person Site Visits for NBCA Centers of Excellence Designation!
